| Name | Title | Contact Details |
|---|---|---|
Daniel Edd |
Chief Human Resources Officer | Profile |
Jennifer Staples |
Associate General Counsel | Profile |
Gabriel Wright |
Associate General Counsel | Profile |
BioCentury Publications, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. BioCentury Publications, Inc. is based in Redwood City, CA. You can find more information on BioCentury Publications, Inc. at www.biocentury.com
GreenTea HP is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NW Portland Area Indian Health Board is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CreoDent Prosthetics is a nationally recognized premier full service dental laboratory and a milling center located in New York. With 2 facilities in NYC and Newburgh, NY, CreoDent specialize in both implant and esthetic dentistry. CreoDent continues to grow and develop new products and services to our clients nationwide. Our products and services have given CreoDent its reputation as the finest dental laboratory to work with.
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.